[Ligand-grafted long circulation liposome and nuclear medicine].
Ligand-grafted long circulation liposome is an advanced and effective carrier in which drugs are modified to be stabilized in the body and delivered properly in time and amount at targeted organs with suppressing side effects.
Ma
Chao
C
Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Kuang
Anren
A
D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004337:Drug Carriers / Q000737:chemistry; D016503:Drug Delivery Systems; D004355:Drug Stability; D006801:Humans; D008024:Ligands; D008081:Liposomes / Q000097:blood / Q000737:chemistry*; D009683:Nuclear Medicine / Q000379:methods*; D010714:Phosphatidylethanolamines / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry*; D011956:Receptors, Cell Surface / Q000378:metabolism; D013499:Surface Properties
C512968:1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide; D004337:Drug Carriers; D008024:Ligands; D008081:Liposomes; D010714:Phosphatidylethanolamines; D011956:Receptors, Cell Surface; D011092:Polyethylene Glycols